<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>mTOR | BM Sci-Tech Memento</title>
    <link>https://example.com/tag/mtor/</link>
      <atom:link href="https://example.com/tag/mtor/index.xml" rel="self" type="application/rss+xml" />
    <description>mTOR</description>
    <generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><lastBuildDate>Tue, 15 Feb 2022 00:00:00 +0000</lastBuildDate>
    <image>
      <url>https://example.com/media/icon_hu1efa9af2edf414d45fb59503b457ea16_13437_512x512_fill_lanczos_center_3.png</url>
      <title>mTOR</title>
      <link>https://example.com/tag/mtor/</link>
    </image>
    
    <item>
      <title>Nicotinamide breaks effector CD8 T cell responses by targeting mTOR signaling</title>
      <link>https://example.com/article/35243268/</link>
      <pubDate>Tue, 15 Feb 2022 00:00:00 +0000</pubDate>
      <guid>https://example.com/article/35243268/</guid>
      <description>&lt;p&gt;&lt;strong&gt;Highlights&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;NAM increases glycolysis while reducing effector cytokine production&lt;/li&gt;
&lt;li&gt;NAM inhibits mTORC1 activation&lt;/li&gt;
&lt;li&gt;In T cells NAM induces the expression of memory markers&lt;/li&gt;
&lt;li&gt;NAM diet supplementation modulates T cell effector potential &lt;em&gt;in vivo&lt;/em&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;Abstract&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Nicotinamide (NAM) shapes T cell responses but its precise molecular mechanism of action remains elusive. Here, we show that NAM impairs naive T cell effector transition but also effector T cells themselves. Although aerobic glycolysis is a hallmark of activated T cells, CD8&lt;sup&gt;+&lt;/sup&gt; T cells exposed to NAM displayed enhanced glycolysis, yet producing significantly less IFNγ. Mechanistically, NAM reduced mTORC1 activity independently of NAD&lt;sup&gt;+&lt;/sup&gt; metabolism, decreasing IFNγ translation and regulating T cell transcriptional factors critical to effector/memory fate. Finally, the role of NAM in a biomedically relevant model of lung injury was tested. Specifically, a NAM-supplemented diet reduced systemic IL-2, antigen-specific T cell clonal expansion, and effector function after inhalation of &lt;em&gt;Staphylococcus aureus&lt;/em&gt; enterotoxin A. These findings identify NAM as a potential therapeutic supplement that uncouples glycolysis from effector cytokine production and may be a powerful treatment for diseases associated with T cell hyperactivation.&lt;/p&gt;
&lt;ul class=&#34;cta-group&#34;&gt;
  
  &lt;li&gt;
    &lt;a href=&#34;https://example.com/article/&#34;  class=&#34;btn btn-primary px-3 py-3&#34;&gt;&lt;font color=&#39;white&#39;&gt; &amp;lt; Back to Articles &lt;/font&gt;&lt;/a&gt;
  &lt;/li&gt;
  
  
  &lt;li&gt;
    &lt;a href=&#34;https://example.com/&#34; &gt;
      Alternative to Homepage &lt;i class=&#34;fas fa-angle-right&#34;&gt;&lt;/i&gt;
    &lt;/a&gt;
  &lt;/li&gt;
  
&lt;/ul&gt;

</description>
    </item>
    
  </channel>
</rss>
